{"id":465370,"date":"2018-04-07T14:58:48","date_gmt":"2018-04-07T13:58:48","guid":{"rendered":"https:\/\/www.intouchrugby.com\/magazine\/?p=465370"},"modified":"2020-11-09T19:49:23","modified_gmt":"2020-11-09T19:49:23","slug":"omron","status":"publish","type":"post","link":"https:\/\/www.intouchrugby.com\/magazine\/omron\/","title":{"rendered":"OMRON HEALTHCARE INTRODUCES AVAIL™, A WIRELESS DEVICE FOR DRUG-FREE PAIN RELIEF. www.OmronHealthcare.com"},"content":{"rendered":"

\"\"<\/h3>\n

OMRON HEALTHCARE INTRODUCES AVAIL™, A WIRELESS DEVICE FOR DRUG-FREE PAIN RELIEF<\/h3>\n

www.OmronHealthcare.com<\/a><\/p>\n

\n

With proven TENS technology and wireless capability, Omron Avail allows for freedom of movement during treatment and treats multiple pain sites simultaneously<\/p>\n

FACEBOOK<\/a> | LINKEDIN | YOUTUBE<\/a> | TWITTER<\/a> | PINTEREST<\/a> | INSTAGRAM<\/a><\/p>\n

In an important development for millions of Americans who suffer from chronic and acute pain, global wellness technology leader, Omron Healthcare, Inc., have launched Avail, an innovative over-the-counter medical device for safe and effective drug-free pain relief. Avail is Omron\u2019s first TENS (Transcutaneous Electrical Nerve Stimulation) unit with wireless and dual channel capability that provides relief from chronic and acute pain. The device can treat multiple pain sites simultaneously and is controlled by Omron\u2019s new mobile app, Omron TENS, enabling users to operate Avail remotely.<\/p>\n

\"\"
\n\u201cPain sufferers are already inconvenienced by their condition. Omron created Avail with wireless capability to restore their freedom of movement while they get pain relief,\u201d said Carol Lucarelli, Director of Marketing and Product Development for Omron Healthcare, Inc. \u201cAnd with two separately programmable TENS devices, the Omron Avail allows for customizable, multi-site treatment for individual aches and pains.\u201d
\nThe Omron Avail comes with two soft, contoured pads that fit comfortably and securely to treat a variety of areas of pain simultaneously. Avail\u2019s five pre-programmed Body Pain Modes soothe lower back, shoulder, knee, elbow and leg pain with recommended therapies. Avail users can also design their own therapies using five additional pulsation modes \u2013 including steady, acupuncture-like, knead, tap and microcurrent \u2013 and 20 different intensity levels.
\nBluetooth\u00ae connectivity on Avail provides wireless control of settings via the Omron TENS app, for on-the-go personal control of pain relief. Omron TENS for smartphones is available for free download on the Apple App Store and Google Play.
\nThe Omron Avail is designed to provide symptomatic relief and management of chronic and acute pain, relief from pain associated with arthritis or with sore or aching muscles of the lower back, arms, legs, shoulders or feet due to strain from exercise or normal household work activities. The device, which has received FDA clearance, is available for purchase at Omronhealthcare.com for $199.99.<\/p>\n

\"\"
\nThe National Institutes of Health has found that more than half of American adults (126 million) reported some type of pain within the last three months, and more than 25 million reported chronic pain (pain every day for the preceding three months.)2
\nAmid rising awareness and concern about opioid addiction, a problem for an estimated two million Americans3, pain sufferers are seeking drug-free alternatives for relief. The Gallup-Palmer College of Chiropractic Annual Study of Americans (conducted in February and March 2017) revealed that 78% of Americans now prefer to try other ways to address their physical pain before taking prescription medications.4
\n\u201cMillions of Americans experience pain on a daily basis, and Omron is investing in TENS device innovation to bring them more options for safe, effective pain management,\u201d said Lucarelli. \u201cAvail is our new offering to bring accessible, convenient, portable drug-free pain relief to those who need it.\u201d
\nA therapy regularly administered by physical therapists and chiropractors, TENS sends stimulating pulses across the surface of the skin and along the nerve strands. The pulses help prevent pain signals from reaching the brain. Electrical stimulation can also trigger the body to release endorphins, which act as natural painkillers, and improve blood circulation. Omron was the first company to market with an over-the-counter FDA-cleared TENS medical device for use at home.<\/p>\n

About Omron Healthcare, Inc.<\/strong><\/p>\n

Omron Healthcare, Inc. is a leading manufacturer and distributor of personal heart health and wellness products. Omron\u2019s market-leading products include home blood pressure monitors and electrotherapy devices. Since Omron invented its first blood pressure monitors more than 40 years ago, the company has been passionate about empowering people to take charge of their health at home through precise technology. Helping people improve their ability to live a healthier life is the heart and soul of Omron\u2019s purpose. For more information, visit www.OmronHealthcare.com<\/a>.<\/p>\n

 <\/p>\n

\"\"\u00a0\u00a0 \"\" \"\"<\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

OMRON HEALTHCARE INTRODUCES AVAIL™, A WIRELESS DEVICE FOR DRUG-FREE PAIN RELIEF www.OmronHealthcare.com With proven TENS technology and wireless capability, Omron Avail allows for freedom of movement during treatment and treats multiple pain sites simultaneously FACEBOOK | LINKEDIN | YOUTUBE | TWITTER | PINTEREST | INSTAGRAM In an important development for millions of Americans who suffer […]<\/p>\n","protected":false},"author":5,"featured_media":465377,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-465370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clubs"],"_links":{"self":[{"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/posts\/465370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/comments?post=465370"}],"version-history":[{"count":4,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/posts\/465370\/revisions"}],"predecessor-version":[{"id":639287,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/posts\/465370\/revisions\/639287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/media\/465377"}],"wp:attachment":[{"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/media?parent=465370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/categories?post=465370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.intouchrugby.com\/magazine\/wp-json\/wp\/v2\/tags?post=465370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}